$DOCU

DocuSign Q2 Profit Rises, Sees Higher Q3 Revenues, Lifts FY27 Revenue Guidance; Shares Up

DocuSign (DOCU) reported Q2 2027 net income of $77.72M ($0.40/ share), up from $62.97M ($0.30/share) YoY, with revenue rising 9% to $875.75M. The company raised FY27 revenue guidance to $3.499B-$3.507B and expects Q3 revenue of $886M-$890M. Shares rose 3.06% to $67.99.

Original reporting
Published Sep 4, 2026, 6:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 7:26 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DocuSign Q2 Profit Rises, Sees Higher Q3 Revenues, Lifts FY27 Revenue Guidance; Shares Up — source image
Decision brief

The 30-second read

$DOCUBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest accelerating adoption of AI‑native agreements, supporting a positive outlook for the stock.

02

Market read

Strong earnings and guidance lift DocuSign and may boost sentiment across the SaaS and AI‑enabled workflow sector.

03

What to watch

Potential competition from integrated platform providers may limit upside.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

DocuSign is a leading provider of electronic signature and agreement management solutions, increasingly leveraging AI.

Company-level read

Ticker impact

$DOCUBullishHigh confidence
Context

DocuSign reported Q2 2027 earnings beat and raised FY2027 revenue guidance.

Expected impact

Expect modest price appreciation in the next trading sessions.

Evidence & confidence

Revenue beat, higher net income, and upgraded guidance signal stronger demand and AI-driven growth.

Market effects

Electronic signature and SaaS sector may see broader optimism.

U.S. tech stocks could benefit from the earnings beat.

AI‑enabled workflow solutions gain credibility worldwide.

Counterpoint

If guidance growth slows later in FY, the rally could be short‑lived.

Key entities

  • DocuSign, Inc.

    Electronic signature and agreement management provider.

Related articles

$DOCUHighAI 8/10

DOCU Q2 Deep Dive: AI Platform Expansion and Margin Gains Shape Outlook

DocuSign (DOCU) reported Q2 2026 revenue of $875.7M, up 9.4% YoY, beating estimates. Non-GAAP EPS was $1.16, 6.8% above consensus. The company expects Q3 revenue around $888M. Growth was driven by its Intelligent Agreement Management (IAM) platform, which now accounts for 15.1% of total annual recurring revenue. Management highlighted AI-driven features and operational discipline as key factors.

$LULUHighAI 8/10

Stocks making the biggest moves after hours: Lululemon, Zscaler, Guidewire Software & more

Lululemon (LULU) fell 18% after weak Q3 guidance. Docusign (DOCU) rose 4% on earnings beat. Zscaler (ZS) gained 2% with strong Q4 results. Adobe (ADBE) dropped 1% on CEO transition. Planet Labs (PL) advanced 7% on Q2 earnings. Asana (ASAN) fell 10% on Q3 guidance. Guidewire (GWRE) dropped 15% on revenue outlook. Samsara (IOT) surged 14% on raised guidance. UiPath (PATH) lost 7% on Q3 outlook.

$DOCUHighAI 8/10

Expected Sales In Q2 CY2026, Stock Soars

DocuSign (DOCU) reported Q2 CY2026 revenue of $875.7M, up 9.4% YoY, exceeding estimates. Non-GAAP EPS was $1.16, 6.8% above consensus. The company expects Q3 revenue of $888M, close to analyst estimates. CEO Allan Thygesen attributed growth to AI-driven momentum. Despite recent slowdowns, the stock rose 7.7% post-results.

$IOTHighAI 8/10

After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM

Samsara (IOT) rose 11% on strong Q2 results and raised guidance. UiPath (PATH) climbed 13% with solid Q2 revenue and upbeat full-year outlook. Docusign (DOCU) gained 7% after a beat-and-raise Q2 report. Asana (ASAN) fell 12% on soft near-term profitability targets. Guidewire (GWRE) dropped 19% due to weak Q1 revenue guidance. Zscaler (ZS) edged up 1% on solid fiscal Q4 results. Planet Labs (PL) jumped 5% after reporting a surprise Q2 profit. Smith & Wesson (SWBI) surged 8.6% on strong Q1 sales.